戻る
Xtant Medical Holdings Inc (XTNT)価格
XTNT 株価推移チャート
XTNT 収入
Xtant Medical Holdings Inc
$0.63
5.38%
$0.03
本日現在の状況：Feb 10, 14:36:03 GMT-5
最新の利益結果: Q3 '25
報告済み: 2025-11-10
歴史的収益
四半期
年次
EPS
収入
Earnings FAQ
XTNTの最近の1株当たり利益（EPS）は予想と比較してどうでしたか？
Xtant Medical Holdings Inc XTNTの前四半期の収益はどうでしたか？
Xtant Medical Holdings Incの収益見積もりはいくらですか？
Xtant Medical Holdings Incの収益品質スコアはどれくらいですか？
Xtant Medical Holdings Incはいつ収益を報告しますか？
Xtant Medical Holdings Incの予想収益はいくらですか？
Xtant Medical Holdings Incは収益予想を上回りましたか？
主要データ
前終値
$0.5983
始値
$0.6173
当日レンジ
$0.61 - $0.6498
52週レンジ
$0.34 - $0.95
取引高
214.2K
平均取引高
223.6K
1株当たり利益(TTM)
-0.04
配当利回り
--
時価総額
$88.2M
XTNTとは何ですか？
Xtant Medical Holdings, Inc. designs, and develops orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. The company is headquartered in Belgrade Montana, Montana and currently employs 217 full-time employees. The company went IPO on 2010-06-30. The firm is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoVive, OsteoFactor, line of 3Demin products, as well as other allografts. The company offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical products, Thoracolumbar products, Sacroiliac Joint products, and Interbody products.